WaveMan · Form 4
Ambrose Kristen insider trades
> Search tickers & screens ⌘K
LIVE

Ambrose Kristen insider trades

Ambrose Kristen has filed 24 Form 4s with the SEC that we hold, all for Vertex Pharmaceuticals INC / Ma (VRTX), as SVP & Chief Accounting Officer. Across all of them we count 0 purchases worth $0 and 19 sales worth $4.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($2.0M). The largest single trade was a sale of 1,557 shares of Vertex Pharmaceuticals INC / Ma worth $762.1K, dated 2026-02-17. The first filing on our record is dated 2022-02-03 and the latest 2026-09-01.

Vertex Pharmaceuticals INC / Ma (VRTX)

SVP & Chief Accounting Officer · 24 filings · 19 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-04-25S, sale reported on Form 4104$28.3K2022-04-27
2022-04-25S, sale reported on Form 480$21.5K2022-04-27
2022-04-25S, sale reported on Form 460$16.0K2022-04-27
2022-04-25S, sale reported on Form 483$22.4K2022-04-27
2023-02-27S, sale reported on Form 442$12.2K2023-02-28
2023-02-27S, sale reported on Form 4183$52.8K2023-02-28
2023-02-27S, sale reported on Form 4982$282.1K2023-02-28
2023-05-30S, sale reported on Form 4289$95.3K2023-06-01
2024-02-12S, sale reported on Form 41,374$577.4K2024-02-13
2024-02-26S, sale reported on Form 4883$375.9K2024-02-27
2024-04-02S, sale reported on Form 4240$100.6K2024-04-03
2025-02-11S, sale reported on Form 41,376$632.7K2025-02-12
2025-02-18S, sale reported on Form 4671$305.3K2025-02-19
2025-02-25S, sale reported on Form 4884$425.2K2025-02-26
2026-02-11S, sale reported on Form 41,376$633.6K2026-02-12
2026-02-17S, sale reported on Form 41,557$762.1K2026-02-19
2026-02-18S, sale reported on Form 4638$302.2K2026-02-19
2026-02-25S, sale reported on Form 4223$108.5K2026-02-26
2026-02-26S, sale reported on Form 4357$172.6K2026-03-02
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1856587) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms